Brain Scientific Inc
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG) systems; NeuroEEG amplifier and desktop software used to store and analyze data captured from the … Read more
Brain Scientific Inc (BRSF) - Net Assets
Latest net assets as of December 2022: $4.32 Million USD
Based on the latest financial reports, Brain Scientific Inc (BRSF) has net assets worth $4.32 Million USD as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.74 Million) and total liabilities ($7.43 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.32 Million |
| % of Total Assets | 36.76% |
| Annual Growth Rate | 138.08% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Brain Scientific Inc - Net Assets Trend (2015–2022)
This chart illustrates how Brain Scientific Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Brain Scientific Inc (2015–2022)
The table below shows the annual net assets of Brain Scientific Inc from 2015 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $4.32 Million | +721.24% |
| 2021-12-31 | $-694.93K | +65.38% |
| 2020-12-31 | $-2.01 Million | -124.18% |
| 2019-12-31 | $-895.53K | -1559.26% |
| 2018-12-31 | $-53.97K | +68.72% |
| 2017-12-31 | $-172.54K | -114.22% |
| 2016-12-31 | $-80.55K | -909.50% |
| 2015-12-31 | $9.95K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Brain Scientific Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3462273100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.24K | 0.03% |
| Other Comprehensive Income | $-4.00K | -0.09% |
| Other Components | $38.94 Million | 902.03% |
| Total Equity | $4.32 Million | 100.00% |
Brain Scientific Inc Competitors by Market Cap
The table below lists competitors of Brain Scientific Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alina Holdings PLC
LSE:ALNA
|
$372.82 |
|
Odel PLC
CM:ODELN0000
|
$372.92 |
|
VN MFG & EXPORT PRO
BE:4V2
|
$373.92 |
|
THE MAURITIUS DEVELOPMENT INVESTMENT TRUST LTD
SEM:MDIT
|
$374.24 |
|
086460
KO:086460
|
$371.50 |
|
Bionik Laboratories Corp
PINK:BNKL
|
$370.65 |
|
NEW VISION PRINTING AND PUBLISHING COMPANY LTD
USE:NVL
|
$370.46 |
|
Metro One Telecommunications Inc
PINK:WOWI
|
$369.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Brain Scientific Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -694,933 to 4,317,222, a change of 5,012,155.
- Net loss of 12,343,858 reduced equity.
- Other comprehensive income decreased equity by 15.
- Other factors increased equity by 17,356,028.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.34 Million | -285.92% |
| Other Comprehensive Income | $-15.00 | -0.0% |
| Other Changes | $17.36 Million | +402.02% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Brain Scientific Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.17x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.55x to 0.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.21 | $0.75 | x |
| 2016-12-31 | $-0.69 | $0.75 | x |
| 2017-12-31 | $-0.02 | $0.75 | x |
| 2018-12-31 | $-0.37 | $0.75 | x |
| 2019-12-31 | $-3.96 | $0.75 | x |
| 2020-12-31 | $-6.36 | $0.75 | x |
| 2021-12-31 | $-1.93 | $0.75 | x |
| 2022-12-31 | $4.53 | $0.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Brain Scientific Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -285.92%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5753.00%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 2.72x
- Recent ROE (-285.92%) is below the historical average (-35.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -0.50% | 0.00% | 0.00x | 1.01x | $-1.04K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-82.68K |
| 2017 | 0.00% | -1310.11% | 3.09x | 0.00x | $-74.74K |
| 2018 | 0.00% | -1310.11% | 0.04x | 0.00x | $-86.60K |
| 2019 | 0.00% | -205.20% | 1681106.53x | 0.00x | $-1.00 Trillion |
| 2020 | 0.00% | -787.25% | 2417592.42x | 0.00x | $-4.28 Trillion |
| 2021 | 0.00% | -3424.57% | 0.02x | 0.00x | $-9.03 Million |
| 2022 | -285.92% | -5753.00% | 0.02x | 2.72x | $-12.78 Million |
Industry Comparison
This section compares Brain Scientific Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Brain Scientific Inc (BRSF) | $4.32 Million | -0.50% | 1.72x | $372.00 |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |